TreeHouse Foods, Inc.
TreeHouse Foods, Inc. (THS) Financial Performance & Income Statement Overview
Review TreeHouse Foods, Inc. (THS) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
TreeHouse Foods, Inc. (THS) Income Statement & Financial Overview
View the income breakdown for TreeHouse Foods, Inc. THS across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $798.00M | $792.00M | $905.70M | $839.10M |
| Cost of Revenue | $658.80M | $676.80M | $728.80M | $707.90M |
| Gross Profit | $139.20M | $115.20M | $176.90M | $131.20M |
| Gross Profit Ratio | $0.17 | $0.15 | $0.20 | $0.16 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $86.30M | $92.10M | $78.70M | $82.00M |
| Operating Expenses | $111.90M | $120.70M | $96.40M | $99.40M |
| Total Costs & Expenses | $770.70M | $797.50M | $825.20M | $807.30M |
| Interest Income | -$200000.00 | $2.80M | $0.00 | $100000.00 |
| Interest Expense | $22.20M | $19.30M | $16.20M | $16.00M |
| Depreciation & Amortization | $0.00 | $41.40M | $37.60M | $36.70M |
| EBITDA | $27.30M | $17.10M | $127.40M | $48.40M |
| EBITDA Ratio | $0.03 | $0.02 | $0.14 | $0.06 |
| Operating Income | $27.30M | -$5.50M | $80.50M | $31.80M |
| Operating Income Ratio | $0.03 | -$0.007 | $0.09 | $0.04 |
| Other Income/Expenses (Net) | -$32.90M | -$38.10M | -$6.90M | -$36.10M |
| Income Before Tax | -$5.60M | -$43.60M | $73.60M | -$4.30M |
| Income Before Tax Ratio | -$0.007 | -$0.06 | $0.08 | -$0.005 |
| Income Tax Expense | -$2.70M | -$11.80M | $14.90M | -$900000.00 |
| Net Income | -$2.90M | -$31.80M | $58.70M | -$3.40M |
| Net Income Ratio | -$0.004 | -$0.04 | $0.06 | -$0.004 |
| EPS | -$0.06 | -$0.63 | $1.16 | -$0.07 |
| Diluted EPS | -$0.06 | -$0.63 | $1.15 | -$0.07 |
| Weighted Avg Shares Outstanding | $50.50M | $50.30M | $50.80M | $51.90M |
| Weighted Avg Shares Outstanding (Diluted) | $50.50M | $50.30M | $51.20M | $51.90M |
The company's financials show resilient growth, with revenue advancing from $839.10M in Q3 2024 to $798.00M in Q2 2025. Gross profit remained healthy with margins at 17% in Q2 2025 compared to 16% in Q3 2024. Operating income hit $27.30M last quarter, sustaining a consistent 3% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $27.30M. Net income rose to -$2.90M, while earnings per share reached -$0.06. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan